CompletedPhase 4NCT00357019

Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis

Studying Vernal keratoconjunctivitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Laboratoires Thea
Principal Investigator: Andréa LEONARDI, Professor
Clinica Oculistica, Padova (Italy)
Intervention: N-acetyl-aspartyl-glutamate (NAAXIA Sine)(drug)
Eligibility: 4 years · All sexes
Timeline: 2001 – 2002

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00357019 on ClinicalTrials.gov

Other trials for Vernal keratoconjunctivitis

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGNCT06913790
Evaluation of Central Corneal Thickness in Patients With Vernal Keratoconjunctivitis Using Topical Steroids
Superior University

See all trials for Vernal keratoconjunctivitis →

← Back to all trials